Oracle partners with Africa Clinical Research Network for first trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Oracle Supports Africa Clinical Research Network (ACRN) to Advance a New Era of Clinical Research, Launches First Trial
May 5, 2026 8:01 AM EDTAfrican-led organization empowers clinicians and research professionals to accelerate equitable research and innovation with Oracle's leading safety solutions and powerful analytics
AUSTIN, Texas, May 5, 2026 /PRNewswire/ -- The Africa Clinical Research Network (ACRN) has launched its first clinical trial with Oracle in Africa, which commenced in February 2026. The PROgnostic Testing to Enhance Clinical Triage of Pre-eclampsia in Africa (PROTECT-Africa) trial aims to define, validate, and evaluate the clinical performance of placental biomarkers... More
